Jørgensen K, Nielsen H, Björnsson E. "Method for the Synthesis of Tipiracil Impurity N2" [P]. European Patent, EP 3310368 A1, 2018-07-20.
Patel M V, Hughes D C, Lee S K. "A Process for Preparing High-Purity Tipiracil Impurity N2" [P]. US Patent, US 9180081 B2, 2015-10-04.
参考文献 Literature
Chen X Y, Liu M, Zhao W Q. "Development and Validation of an LC-MS/MS Method for the Determination of 替匹嘧啶杂质N2 in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2021, 440, 8752-8758.
Fischer P, Wagner E. "A Stability-Indicating HPLC Method for the Separation and Quantification of 替匹嘧啶杂质N2 as an Impurity". Talanta, 2018, 2203, (2), 3867-3889.
Brown R C, Davis S M. "Identification and Structural Characterization of a Novel Degradation Product of Tipiracil Impurity N2 Using HRMS and NMR". Phytochemistry, 2012, 1253, 4410-4418.
Kim S H, Park J Y. "Forced Degradation Studies to Evaluate 替匹嘧啶杂质N2 Profile in Drug Substances According to ICH Guidelines". Chemosphere, 2011, 727, 7231-7260.